Pharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors like pharma offer minimal risk. Notable picks include Lupin, Sun Pharma, and Dr Reddy’s. The sector saw significant foreign inflows, driven by the performance of the generic drug Revlimid.
Sebi imposes Rs 10 lakh fine on Anand Rathi for violation of stock brokers’ norms
India’s market regulator Sebi fined Anand Rathi Share and Stock Brokers ₹10 lakh after inspections found multiple regulatory violations, including delayed glitch reporting, excessive capacity